beta

ALLK

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-08-2018 08-29-2018
Actual EPS -0.34 -4.17
Consensus EPS -0.24 -0.26
Estimated EPS -0.24 -0.26
Number of Estimates 2 2
EPS Surprise -$0.10 -$3.91

Stats

Summary

Market Cap:

Primary Exchange:

Website: /stocks/allk

Shares Outstanding:

Float:

Dividend: (%)

Beta:

Sector:

Industry:

Short Interest ():

Ethical Flags

Longest drawdown: 167 trading days

From: 2018-08-02 To: 2018-09-04

Lowest Point:

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Allakos reports Q3 results

via: SeekingAlpha at 2018-11-08 17:13:33:000

Allakos (NASDAQ: ALLK ): Q3 GAAP EPS of -$0.34. Cash, cash equivalents and marketable securities of$193.5M Press Release More news on: Allakos, Earnings news and commentary, Healthcare stocks news, read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Looking Beyond The Election (Stocks To Watch Podcast)

via: SeekingAlpha at 2018-11-04 06:30:58:000

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look f… read more...

Stocks To Watch: Looking Beyond The Election

via: SeekingAlpha at 2018-11-03 09:26:43:000

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Yep, there is an election next week that's going to steal some headlines, but inves… read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

Allakos reports Q2 results

via: SeekingAlpha at 2018-08-29 16:10:16:000

Allakos (NASDAQ: ALLK ): Q2 GAAP EPS of -$4.17. More news on: Allakos, Earnings news and commentary, Healthcare stocks news, Read more … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

U.S. IPO Week Ahead: One Biotech On The Calendar As August Slowdown Sets In

via: SeekingAlpha at 2018-08-11 12:40:51:000

One biotech, Aridis Pharmaceuticals, is on the IPO calendar for the week ahead to raise $28 million. Insiders intend to buy up to 89% of the IPO. A holdover from last week, small healthcare company Bionano Genomics will again attempt to price. The slowdown in IPO activity marks the start of … read more...

Roche's Bet On Allakos Is Too Expensive

via: SeekingAlpha at 2018-07-31 20:44:38:000

Exploring treatments for various eosinophil and mast cell-related diseases, which a few competitors are investigating, Allakos (ALLK) seems to have excited the market. The fact that Roche Holding (RHHBF) has invested in the company will hold the attention of many investors. With that, the shar… read more...

Roche's Bet On Allakos Is Too Expensive

via: SeekingAlpha at 2018-07-31 20:44:38:000

Exploring treatments for various eosinophil and mast cell-related diseases, which a few competitors are investigating, Allakos (ALLK) seems to have excited the market. The fact that Roche Holding (RHHBF) has invested in the company will hold the attention of many investors. With that, the shar… read more...

Roche's Bet On Allakos Is Too Expensive

via: SeekingAlpha at 2018-07-31 20:44:38:000

Exploring treatments for various eosinophil and mast cell-related diseases, which a few competitors are investigating, Allakos (ALLK) seems to have excited the market. The fact that Roche Holding (RHHBF) has invested in the company will hold the attention of many investors. With that, the shar… read more...

Roche's Bet On Allakos Is Too Expensive

via: SeekingAlpha at 2018-07-31 20:44:38:000

Exploring treatments for various eosinophil and mast cell-related diseases, which a few competitors are investigating, Allakos (ALLK) seems to have excited the market. The fact that Roche Holding (RHHBF) has invested in the company will hold the attention of many investors. With that, the shar… read more...

Roche's Bet On Allakos Is Too Expensive

via: SeekingAlpha at 2018-07-31 20:44:38:000

Exploring treatments for various eosinophil and mast cell-related diseases, which a few competitors are investigating, Allakos (ALLK) seems to have excited the market. The fact that Roche Holding (RHHBF) has invested in the company will hold the attention of many investors. With that, the shar… read more...

Roche's Bet On Allakos Is Too Expensive

via: SeekingAlpha at 2018-07-31 20:44:38:000

Exploring treatments for various eosinophil and mast cell-related diseases, which a few competitors are investigating, Allakos (ALLK) seems to have excited the market. The fact that Roche Holding (RHHBF) has invested in the company will hold the attention of many investors. With that, the shar… read more...

Roche's Bet On Allakos Is Too Expensive

via: SeekingAlpha at 2018-07-31 20:44:38:000

Exploring treatments for various eosinophil and mast cell-related diseases, which a few competitors are investigating, Allakos (ALLK) seems to have excited the market. The fact that Roche Holding (RHHBF) has invested in the company will hold the attention of many investors. With that, the shar… read more...

Roche's Bet On Allakos Is Too Expensive

via: SeekingAlpha at 2018-07-31 20:44:38:000

Exploring treatments for various eosinophil and mast cell-related diseases, which a few competitors are investigating, Allakos (ALLK) seems to have excited the market. The fact that Roche Holding (RHHBF) has invested in the company will hold the attention of many investors. With that, the shar… read more...

Roche's Bet On Allakos Is Too Expensive

via: SeekingAlpha at 2018-07-31 20:44:38:000

Exploring treatments for various eosinophil and mast cell-related diseases, which a few competitors are investigating, Allakos (ALLK) seems to have excited the market. The fact that Roche Holding (RHHBF) has invested in the company will hold the attention of many investors. With that, the shar… read more...

Roche's Bet On Allakos Is Too Expensive

via: SeekingAlpha at 2018-07-31 20:44:38:000

Exploring treatments for various eosinophil and mast cell-related diseases, which a few competitors are investigating, Allakos (ALLK) seems to have excited the market. The fact that Roche Holding (RHHBF) has invested in the company will hold the attention of many investors. With that, the shar… read more...

Rounds Report: Newly IPO Stock Allakos Can Be A Promising Investment

via: SeekingAlpha at 2018-07-25 19:05:36:000

In other words, if the right stocks are bought and held long enough they will always produce some profit. Usually, they will produce a handsome profit. However, to produce close to the maximum profit, the kind of spectacular profit defined earlier, some consideration must be given to timin… read more...

Rounds Report: Newly IPO Stock Allakos Can Be A Promising Investment

via: SeekingAlpha at 2018-07-25 19:05:36:000

In other words, if the right stocks are bought and held long enough they will always produce some profit. Usually, they will produce a handsome profit. However, to produce close to the maximum profit, the kind of spectacular profit defined earlier, some consideration must be given to timin… read more...

Rounds Report: Newly IPO Stock Allakos Can Be A Promising Investment

via: SeekingAlpha at 2018-07-25 19:05:36:000

In other words, if the right stocks are bought and held long enough they will always produce some profit. Usually, they will produce a handsome profit. However, to produce close to the maximum profit, the kind of spectacular profit defined earlier, some consideration must be given to timin… read more...

Rounds Report: Newly IPO Stock Allakos Can Be A Promising Investment

via: SeekingAlpha at 2018-07-25 19:05:36:000

In other words, if the right stocks are bought and held long enough they will always produce some profit. Usually, they will produce a handsome profit. However, to produce close to the maximum profit, the kind of spectacular profit defined earlier, some consideration must be given to timin… read more...

Rounds Report: Newly IPO Stock Allakos Can Be A Promising Investment

via: SeekingAlpha at 2018-07-25 19:05:36:000

In other words, if the right stocks are bought and held long enough they will always produce some profit. Usually, they will produce a handsome profit. However, to produce close to the maximum profit, the kind of spectacular profit defined earlier, some consideration must be given to timin… read more...

Rounds Report: Newly IPO Stock Allakos Can Be A Promising Investment

via: SeekingAlpha at 2018-07-25 19:05:36:000

In other words, if the right stocks are bought and held long enough they will always produce some profit. Usually, they will produce a handsome profit. However, to produce close to the maximum profit, the kind of spectacular profit defined earlier, some consideration must be given to timin… read more...

Rounds Report: Newly IPO Stock Allakos Can Be A Promising Investment

via: SeekingAlpha at 2018-07-25 19:05:36:000

In other words, if the right stocks are bought and held long enough they will always produce some profit. Usually, they will produce a handsome profit. However, to produce close to the maximum profit, the kind of spectacular profit defined earlier, some consideration must be given to timin… read more...

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week

via: SeekingAlpha at 2018-07-21 11:55:51:000

The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. Five biotechs went public, including top performer Allakos, which finished the week up 95%. Tilray grabbed headlines as the first marijuana seller t… read more...

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week

via: SeekingAlpha at 2018-07-21 11:55:51:000

The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. Five biotechs went public, including top performer Allakos, which finished the week up 95%. Tilray grabbed headlines as the first marijuana seller t… read more...

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week

via: SeekingAlpha at 2018-07-21 11:55:51:000

The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. Five biotechs went public, including top performer Allakos, which finished the week up 95%. Tilray grabbed headlines as the first marijuana seller t… read more...

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week

via: SeekingAlpha at 2018-07-21 11:55:51:000

The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. Five biotechs went public, including top performer Allakos, which finished the week up 95%. Tilray grabbed headlines as the first marijuana seller t… read more...

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week

via: SeekingAlpha at 2018-07-21 11:55:51:000

The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. Five biotechs went public, including top performer Allakos, which finished the week up 95%. Tilray grabbed headlines as the first marijuana seller t… read more...

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week

via: SeekingAlpha at 2018-07-21 11:55:51:000

The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. Five biotechs went public, including top performer Allakos, which finished the week up 95%. Tilray grabbed headlines as the first marijuana seller t… read more...

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week

via: SeekingAlpha at 2018-07-21 11:55:51:000

The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. Five biotechs went public, including top performer Allakos, which finished the week up 95%. Tilray grabbed headlines as the first marijuana seller t… read more...

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week

via: SeekingAlpha at 2018-07-21 11:55:51:000

The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. Five biotechs went public, including top performer Allakos, which finished the week up 95%. Tilray grabbed headlines as the first marijuana seller t… read more...

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week

via: SeekingAlpha at 2018-07-21 11:55:51:000

The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. Five biotechs went public, including top performer Allakos, which finished the week up 95%. Tilray grabbed headlines as the first marijuana seller t… read more...

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week

via: SeekingAlpha at 2018-07-21 11:55:51:000

The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. Five biotechs went public, including top performer Allakos, which finished the week up 95%. Tilray grabbed headlines as the first marijuana seller t… read more...

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week

via: SeekingAlpha at 2018-07-21 11:55:51:000

The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. Five biotechs went public, including top performer Allakos, which finished the week up 95%. Tilray grabbed headlines as the first marijuana seller t… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX